KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Inventory Average (2016 - 2024)

Historic Inventory Average for Nektar Therapeutics (NKTR) over the last 14 years, with Q2 2024 value amounting to $15.4 million.

  • Nektar Therapeutics' Inventory Average fell 2497.56% to $15.4 million in Q2 2024 from the same period last year, while for Jun 2024 it was $15.4 million, marking a year-over-year decrease of 2497.56%. This contributed to the annual value of $17.7 million for FY2023, which is 85.71% up from last year.
  • As of Q2 2024, Nektar Therapeutics' Inventory Average stood at $15.4 million, which was down 2497.56% from $16.2 million recorded in Q1 2024.
  • Over the past 5 years, Nektar Therapeutics' Inventory Average peaked at $20.5 million during Q2 2023, and registered a low of $12.7 million during Q3 2020.
  • Its 5-year average for Inventory Average is $16.1 million, with a median of $15.7 million in 2021.
  • Its Inventory Average has fluctuated over the past 5 years, first skyrocketed by 2651.17% in 2023, then crashed by 2497.56% in 2024.
  • Nektar Therapeutics' Inventory Average (Quarter) stood at $14.1 million in 2020, then rose by 10.46% to $15.6 million in 2021, then rose by 22.9% to $19.1 million in 2022, then dropped by 18.37% to $15.6 million in 2023, then fell by 1.69% to $15.4 million in 2024.
  • Its Inventory Average was $15.4 million in Q2 2024, compared to $16.2 million in Q1 2024 and $15.6 million in Q4 2023.